fda glp-1 safety alert october 2025 Societies take stand against off-brand GLP-1s over concerns GLP-1 Weight-Loss Drug Demonstration Begins

Because absorption differs, oral semaglutide requires careful dosing and timing, and some people experience side effects differently than with injections

Based on typical drug development timelines (3-5 years from first-in-human trials to approval), an oral dual agonist is unlikely before the late 2020s at the earliest

Recently, however, some people have been microdosing GLP-1 medications as their preferred way to take these medications

Horm Metab Res 2004

This ongoing support helps patients build better nutrition, sleep, and exercise habits, making it easier to turn short-term results into long-term success

Use the decision tree + troubleshooting checklist to confirm the likely driver and rule out false stall factors first